Basics |
Company: |
Charles River Laboratories International, Inc. |
IPO Date: |
June 23, 2000 |
Sector: |
Healthcare |
Industry: |
Life Sciences Tools and Services |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$1.32 | 1.17%
|
Avg Daily Range (30 D): |
$2.31 | 1.35%
|
Avg Daily Range (90 D): |
$2.72 | 1.44%
|
Institutional Daily Volume |
Avg Daily Volume: |
.52M |
Avg Daily Volume (30 D): |
.75M |
Avg Daily Volume (90 D): |
.62M |
Trade Size |
Avg Trade Size (Sh.): |
95 |
Avg Trade Size (Sh.) (30 D): |
43 |
Avg Trade Size (Sh.) (90 D): |
39 |
Institutional Trades |
Total Inst.Trades: |
12,772 |
Avg Inst. Trade: |
$3.72M |
Avg Inst. Trade (30 D): |
$12.28M |
Avg Inst. Trade (90 D): |
$11.03M |
Avg Inst. Trade Volume: |
.04M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$7.19M |
Avg Closing Trade (30 D): |
$19.97M |
Avg Closing Trade (90 D): |
$17.9M |
Avg Closing Volume: |
46.27K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$8.04
|
$1.34
|
$1.75
|
Diluted EPS
|
$8.01
|
$1.33
|
$1.74
|
Revenue
|
$ 4.06B
|
$ 1.01B
|
$ 1.03B
|
Gross Profit
|
$
|
$ 349.02M
|
$ 353.71M
|
Net Income / Loss
|
$ 427.99M
|
$ 70.3M
|
$ 94.26M
|
Operating Income / Loss
|
$ 527.96M
|
$ 117.41M
|
$ 151.65M
|
Cost of Revenue
|
$
|
$ 660.74M
|
$ 672.4M
|
Net Cash Flow
|
$ 46.02M
|
$ 30.64M
|
$ -157.53M
|
PE Ratio
|
18.98
|
|
|
|